These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

861 related items for PubMed ID: 24656794

  • 1. Intra-arterial chemotherapy for retinoblastoma in 70 eyes: outcomes based on the international classification of retinoblastoma.
    Shields CL, Manjandavida FP, Lally SE, Pieretti G, Arepalli SA, Caywood EH, Jabbour P, Shields JA.
    Ophthalmology; 2014 Jul; 121(7):1453-60. PubMed ID: 24656794
    [Abstract] [Full Text] [Related]

  • 2. Fluorescein angiographic findings after intra-arterial chemotherapy for retinoblastoma.
    Bianciotto C, Shields CL, Iturralde JC, Sarici A, Jabbour P, Shields JA.
    Ophthalmology; 2012 Apr; 119(4):843-9. PubMed ID: 22137042
    [Abstract] [Full Text] [Related]

  • 3. Rescue intra-arterial chemotherapy following retinoblastoma recurrence after initial intra-arterial chemotherapy.
    Shields CL, Say EA, Pointdujour-Lim R, Cao C, Jabbour PM, Shields JA.
    J Fr Ophtalmol; 2015 Jun; 38(6):542-9. PubMed ID: 25982423
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Intra-arterial chemotherapy for retinoblastoma: report No. 1, control of retinal tumors, subretinal seeds, and vitreous seeds.
    Shields CL, Bianciotto CG, Jabbour P, Ramasubramanian A, Lally SE, Griffin GC, Rosenwasser R, Shields JA.
    Arch Ophthalmol; 2011 Nov; 129(11):1399-406. PubMed ID: 21670328
    [Abstract] [Full Text] [Related]

  • 8. OPHTHALMIC VASCULAR EVENTS AFTER INTRA-ARTERIAL CHEMOTHERAPY FOR RETINOBLASTOMA: Real-World Comparison Between Primary and Secondary Treatments.
    Ancona-Lezama D, Dalvin LA, Lucio-Alvarez JA, Jabbour P, Shields CL.
    Retina; 2019 Dec; 39(12):2264-2272. PubMed ID: 30204728
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Management and outcome of retinoblastoma with vitreous seeds.
    Manjandavida FP, Honavar SG, Reddy VA, Khanna R.
    Ophthalmology; 2014 Feb; 121(2):517-24. PubMed ID: 24572675
    [Abstract] [Full Text] [Related]

  • 13. Intra-arterial chemotherapy for retinoblastoma: Two-year results from tertiary eye-care center in India.
    Rishi P, Sharma T, Sharma M, Maitray A, Dhami A, Aggarwal V, Munusamy S, Ravikumar R, Ramamurthy S.
    Indian J Ophthalmol; 2017 Apr; 65(4):311-315. PubMed ID: 28513496
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Combined intravitreal melphalan and topotecan for refractory or recurrent vitreous seeding from retinoblastoma.
    Ghassemi F, Shields CL, Ghadimi H, Khodabandeh A, Roohipoor R.
    JAMA Ophthalmol; 2014 Aug; 132(8):936-41. PubMed ID: 24789622
    [Abstract] [Full Text] [Related]

  • 16. Secondary and tertiary intra-arterial chemotherapy for massive persistent or recurrent subretinal retinoblastoma seeds following previous chemotherapy exposure: long-term tumor control and globe salvage in 30 eyes.
    Say EA, Iyer PG, Hasanreisoglu M, Lally SE, Jabbour P, Shields JA, Shields CL.
    J AAPOS; 2016 Aug; 20(4):337-42. PubMed ID: 27328850
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 44.